ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
89 hedge funds and large institutions have $223M invested in Antares Pharma, Inc. in 2013 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
38% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 21
Holders
89
Holding in Top 10
1
Calls
$947K
Puts
$550K
Top Buyers
| 1 | +$9.43M | |
| 2 | +$6.65M | |
| 3 | +$5.49M | |
| 4 |
BC
Broadfin Capital
New York
|
+$3.58M |
| 5 |
ACM
Ashford Capital Management
Wilmington,
Delaware
|
+$2.99M |
Top Sellers
| 1 | -$1.05M | |
| 2 | -$513K | |
| 3 | -$510K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$361K |
| 5 |
Morgan Stanley
New York
|
-$337K |